@UQH0YwFd2i5W77T CDC発表の生データを統計処理したものになります https://t.co/8JbseTzdX1
@TheCunce @JenniferGrenke @Cobratate The bivalent vaccine is extremely effective. https://t.co/kbcJRrGqUX
@philesh92 @SaiyanBio On commence à en avoir, pour l'instant à propos des infections symptomatiques. Le CDC a fournit des données de %VE absolue, et de %VE relative (versus rappel monovalent originel)... https://t.co/vsf23s3RDT https://t.co/DyzawgtrWw
New- In this study, relative benefits of a booster compared with single vaccine doses alone increased with time since receipt of last dose. In-depth study https://t.co/hR0PKnIcMk
RT @jimbuctwit: Please read the first paragraph in the screen clip below. If you've wondered if the updated COVID booster is worth the fuss…
RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx
RT @C_A_Gustave: @HumanFrenchBot Au niveau clinique, on mesure le résultat à l'échelle populationnelle, donc sur un mix de personnes antéri…
RT @DrTomFrieden: For those who were looking for further evidence of the importance of an Omicron booster, here it is! Even if you’ve been…
RT @DrTomFrieden: For those who were looking for further evidence of the importance of an Omicron booster, here it is! Even if you’ve been…
RT @jimbuctwit: Please read the first paragraph in the screen clip below. If you've wondered if the updated COVID booster is worth the fuss…
Please read the first paragraph in the screen clip below. If you've wondered if the updated COVID booster is worth the fuss the answer is YES. Link to this weekly review: https://t.co/EO4vO5O533 Link to the referenced report: https://t.co/ctW59wm2Sr http
6/6 NOTE : ces données n'incluent pas encore les nouveaux variants à fort échappement immunitaire (BQ.1.1, XBB, et nombreux autres en cours d'émergence). Ni les données du rappel bivalent actuel (cf. données du CDC, contre infection sympto) https://t.co/vs
@HumanFrenchBot Au niveau clinique, on mesure le résultat à l'échelle populationnelle, donc sur un mix de personnes antérieurement infectées par Omicron ou pas, et on mesure une résultante, qui donne un avantage de ~30 à 60% pour le rappel bivalent versus
RT @Scary7Dr: First published results for the bivalent mRNA Covid vaccines show greater protection than monovalent https://t.co/qE82kGWE4o
@stezia7 @Oak_Trees19 @DrHoenderkamp So? It was designed to reduce serious illness, hospitalisations and deaths. If you do catch it its significantly less serious and shorter than being unvaccinated and if you have the new bivalent booster it adds protecti
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection “Staying up to date with COVID-19 vaccination, including getting a bivalent booster dose when eligible, is critical to maximizing protection against COVID-19” https://t
RT @Lily4Lily2: Resultaten van een recent rapport van de Centers for Disease Control and Prevention suggereren dat de COVID-19 bivalente #B…
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
First published results for the bivalent mRNA Covid vaccines show greater protection than monovalent https://t.co/qE82kGWE4o
@MartyMakary Uptake has nothing to do with data. New variants will always come up and cause questions. People are being flooded with continual @GOP disinformation. https://t.co/46iH0udTW5
Resultaten van een recent rapport van de Centers for Disease Control and Prevention suggereren dat de COVID-19 bivalente #Booster weinig meer doet dan het beschermingsniveau herstellen naar het niveau van vóór de #Vaccinatie. https://t.co/Hh11C8DKOm
People can do what they want, but the boost was worth getting a fourth Bill Gates chip implant to me. YMMV! https://t.co/wxQAPigHvU
RT @ringleader_: U.S.-authorized bivalent mRNA booster formulations, bivalent boosters provided significant additional protection against s…
U.S.-authorized bivalent mRNA booster formulations, bivalent boosters provided significant additional protection against symptomatic SARS-CoV-2 infection in persons who had previously received 2, 3, or 4 monovalent vaccine doses https://t.co/DsrSafnNIn
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022 https://t.co/36pChgXkJB https://t.co/ld7VyVCFvn
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 https://t.co/LDpjPfD6Uu
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 Weekly / December 2, 2022 / 71(48);1526–1530 via Center…https://t.co/dI45ff5aCf
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 https://t.co/jJJZJIwrsA
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @RIHEALTH: Data show that people who got updated, #BivalentBoosters have better protection against #COVID19 than people who did not. For…
RT @MartyMakary: CDC just released its bivalent vax study-says effectiveness "should be interpreted with caution because unvaccinated perso…
RT @RIHEALTH: Data show that people who got updated, #BivalentBoosters have better protection against #COVID19 than people who did not. For…
RT @RIHEALTH: Data show that people who got updated, #BivalentBoosters have better protection against #COVID19 than people who did not. For…
RT @RIHEALTH: Data show that people who got updated, #BivalentBoosters have better protection against #COVID19 than people who did not. For…
RT @RIHEALTH: Data show that people who got updated, #BivalentBoosters have better protection against #COVID19 than people who did not. For…
RT @ja_ko_study: 忽那医師がオミクロン対応コロナワクチンの接種を勧める根拠となったCDCの報告書で気になった点をまとめます。 https://t.co/6WChj0l1cq
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @shuichiotsu: ・出典 https://t.co/fqjWjxqUxM オミクロン株対応二価ワクチンで実世界での有効性が示されたとの研究 アメリカでの研究で、BA.4/BA.5対応型の結果 接種の追加で有効性の改善を認め、一部に流れている、新ワクチンを打…
RT @FaitsetSources: Quelle protection additionnelle peut-on attendre d'une seule dose de rappel en vaccin bivalent après 2, 3 ou 4 doses de…
RT @Alaska_DOH: Read the MMWR report, Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, A…
忽那医師がオミクロン対応コロナワクチンの接種を勧める根拠となったCDCの報告書で気になった点をまとめます。 https://t.co/6WChj0l1cq
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @annezinkmd: Test and Treat! Great to see this MMWR showing a decrease hospitalization for those who took Paxlovid - a 5 day course of…
Test and Treat! Great to see this MMWR showing a decrease hospitalization for those who took Paxlovid - a 5 day course of pills and the main treatment now that the major monoclonal antibody doesn’t work on Omicron subvariants BQ.1 and BQ.1.1 https://t.c
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
https://t.co/xzRvGtDlYS The vaccine effectiveness in preventing a positive COVID-19 test was -17% for people who had received two shots, -36% for three shots and -45% for four shots. This is evidence that the more monovalent shots people had, the less prot
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
I think they have this a bit backwards
Data show that people who got updated, #BivalentBoosters have better protection against #COVID19 than people who did not. For more information, see this latest study from the CDC: https://t.co/YPyi2so9cJ https://t.co/a78XB60eLI
RT @TCBPubHealth: COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospita…
COVID hospitalizations trending up (on top of flu). Hospital bed capacity is very tight... made worse with recent hospital bed closures. COVID boosters make a difference. https://t.co/hX5tbGSqD1 @BowerSOPH @MSMA1 @msdh @MHA https://t.co/QeChkYFi4j
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 https://t.co/9up8umyeRk
RT @Panda31808732: Étude aux États-Unis trouvant que le bivalent fournit bien un peu de protection contre l'infection symptomatique chez le…
Quelle protection additionnelle peut-on attendre d'une seule dose de rappel en vaccin bivalent après 2, 3 ou 4 doses de vaccin monovalent ? C'est à cette question que répond le tableau 2🔽 #vaccination #vaccin #COVID19
RT @ejustin46: CDC. VACCINE EFFECTIVENESS for a single bivalent mRNA COVID-19 booster dose received after 2, 3, or 4 doses of monovalent v…
@vegananne @Fishyfish666 @wpeenz @US_FDA Just adding on reasons for lost credibility. CDC data link https://t.co/y5bfWyamDI & good article on why important to wait MIN of 6 Mos (not necessarily optimal but minimum) https://t.co/DgwfUz9LWC
RT @coastalhealth91: On the fence about getting the new bivalent COVID booster shot? A recent study found that updated booster shots provid…
RT @xjR1BqbrppuegLj: 米CDCがオミクロン対応2価💉の有効性を始めて算出したとの11/22の週次レポート(MMWR) レポート自体は2価💉が効果あるよと言いたいようですが、生データを見ると今までの武漢💉(1価)がマイナス効果ということが、暗に示されています…
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
Link-Gelles et al. han observat un augment de la protecció front la infecció per SARS-CoV-2 dels vaccins bivalents (que incorporen informació sobre les noves variants del virus). https://t.co/tq56N2zNXF
Nuevos estudios muestran que el refuerzo actualizado brinda protección adicional contra el COVID-19 sintomático. Más información en https://t.co/a6tR8F9P7V https://t.co/bFjAXvF8jw
#VaxFact: New studies show the updated booster provides additional protection from symptomatic COVID-19. Learn more at https://t.co/1FoYlh56Ex https://t.co/G5NMjdIS56
RT @ConservaJoker: 1/2 Per this @CDCGov #COVID19 "vaccines" study: Only 24% of 121,687 patients who tested positive were unvaccinated. Se…
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @ramos262740691: 【危険信号】 さて、cdcが出した二価ワクのVE速報 https://t.co/haEsT9LbGx
RT @ramos262740691: あ、そもそも二価ワクのBA.5へのVE40%って前提はこの最近のCDC速報です。 既感染者込みでの解析(我らがトップスター米国)なので、そもそも未感染者の方はもっと低めを見とくのが良いですよ。 https://t.co/kmXlKTbDmh
RT @coastalhealth91: On the fence about getting the new bivalent COVID booster shot? A recent study found that updated booster shots provid…